. . . . . . . "[Calycosin has an advantage on inhibiting breast cancer growth in comparison with formononetin, which is obtained by ER?-mediated regulation of IGF-1R signaling pathways and miR-375 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:19:24+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .